Landscape Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Landscape Capital Management's TXG Position: Q3 2026 in Review
Landscape Capital Management sold out of 10x Genomics (TXG) in Q3 2026, closing a stake of 15,998 shares — an estimated $613K sold.
Landscape Capital Management first reported a position in TXG in Q3 2019 and held it in 5 quarters. The position peaked at $2.28M in Q1 2026. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Landscape Capital Management reported no remaining 10x Genomics position as of Q3 2026 after selling out during the quarter.
- Landscape Capital Management sold 15,998 10x Genomics shares in Q3 2026, an estimated $613K.
- Landscape Capital Management first reported a position in 10x Genomics in Q3 2019 and held it in 5 quarters.
- Landscape Capital Management's 10x Genomics position peaked at $2.28M in Q1 2026.
- 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Landscape Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.